ILC2s, generally considered to be the most important ILC subtype in AD pathogenesis, promote the development of Th2 cells by producing characteristic cytokines, such as IL-13 and IL-5, and it has been demonstrated that ILC2 deficiency leads to severe defects in Th2 cell immune responses (57). This evidence concerns the gene IL5 and Alzheimer disease.